The tumor spectrum of Pirh2−/−p53−/− mice was significantly altered compared to Pirh2−/− and p53−/− mutants and consisted of adenocarcinomas, sarcomas, thymomas and T-cell lymphomas (Figure 8B, 8E and 8F; Table S2). Here, TP53 is linked to thymoma.